Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COIITSS: Corticotherapy and Intensive Insulin Therapy for Septic Shock
NCT00320099Phase 3Completed
- Sponsor
- Université de Versailles Saint-Quentin-en-Yvelines
- Start
- Jan 2006
- Primary completion
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fludrocortisone, human insulin in septic shock, sponsored by Université de Versailles Saint-Quentin-en-Yvelines. Started Jan 2006; status: completed.
02
Drugs
fludrocortisonehuman insulin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00320099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320099.